Table of Contents
Biotechs have one shot at getting study design and execution right. How do they navigate the choice between specialised vs large CROs? And how have smaller biotech successfully navigated the new prerequisite of manufacturing in the U.S.?
Treehill Partners is an international strategic and financial advisory firm focused exclusively on healthcare.
At JPM 2026, Treehill ran a series of closed-door roundtables exploring the most pertinent topics in biotech and pharma.
Onyx sat down with CEO Ali Pashazadeh to find out more.
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Comments